Lower mean nocturnal baseline impedance in erosive reflux disease, Barrett’s Esophagus, and elevated body mass index compared to nonerosive reflux disease
Diseases of the Esophagus · 2026
DOI: 10.1093/dote/doaf129 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Diseases of the Esophagus, 2026. Verfasst von Chaewon Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA. Hauptthemen laut MEDLINE: Gastroesophageal Reflux, Barrett Esophagus, Electric Impedance, Body Mass Index. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Diagnosing gastroesophageal reflux disease (GERD) remains challenging in patients with inconclusive endoscopic findings or acid exposure time. Mean nocturnal baseline impedance (MNBI) is a diagnostic metric to delineate pathological GERD. This study evaluates MNBI in relation to GERD phenotypes, antisecretory medication use, symptomatology, and other covariates to validate its integration into recommendations in light of Lyon consensus updates. We conducted a retrospective analysis of 550 patients who underwent esophagogastroduodenoscopy and 24-hour pH-impedance testing. A multivariate linear model inferred the association between medication status and MNBI, adjusting for covariates. Interaction terms determined moderation of patient medication status on MNBI by other clinical covariates. Medication status significantly influenced MNBI, independent of covariates. Medicated patients had mean MNBI 0.52 kΩ greater (95% CI: 0.27–7.8, P < 0.001) than non-medicated patients. MNBI was 0.78 kΩ lower (95% CI: −1.2 to −0.41, P < 0.001) in patients with erosive disease and 1.0 kΩ lower (95% CI: −1.5 to −0.5, P < 0.001) in those with Barrett’s esophagus. Additionally, MNBI decreased by 0.02 kΩ for every one-unit body mass index increase (95% CI: −0.04 to −0.01, P = 0.006). This study validates lower MNBI as a potential surrogate marker for GERD, particularly in more erosive presentations. Increased MNBI in medicated patients highlights antisecretory therapy as a potential confounding factor, reinforming the need for off-therapy testing. The study is strengthened by its large population, though limited by retrospectivity. The findings support both MNBI as a valuable diagnostic tool in GERD assessment and the need to further standardize MNBI cutoffs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
- Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Internal Medicine, Section of Gastroenterology, Atrium Health Wake Forest Baptist, Winston-Salem, NC, USA.
ORCID-Profile: Chaewon Jeong
Zitieren
APA
Jeong, C., Edmunds, C. E., McCollum, B. C., White, B. N., & Clayton, S. B. (2026). Lower mean nocturnal baseline impedance in erosive reflux disease, Barrett’s Esophagus, and elevated body mass index compared to nonerosive reflux disease. Diseases of the Esophagus. https://doi.org/10.1093/dote/doaf129
Vancouver
Jeong C, Edmunds CE, McCollum BC, White BN, Clayton SB. Lower mean nocturnal baseline impedance in erosive reflux disease, Barrett’s Esophagus, and elevated body mass index compared to nonerosive reflux disease. Diseases of the Esophagus. 2026. doi:10.1093/dote/doaf129
BibTeX
@article{Jeong2026,
author = {Jeong, Chaewon and Edmunds, Carter E and McCollum, Bailey C and White, Brian N and Clayton, Steven B},
title = {Lower mean nocturnal baseline impedance in erosive reflux disease, Barrett’s Esophagus, and elevated body mass index compared to nonerosive reflux disease},
journal = {Diseases of the Esophagus},
year = {2026},
doi = {10.1093/dote/doaf129}
}
EUVIMED